Trial intelligence / Profile preview

Pharmacokinetics of oseltamivir in ICU patients with influenza A H1N1 2009 infection

2009-017350-13Phase 4Completed

Sponsor
Erasmus Hospital
Start
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of oseltamivir in Influenza A infection, sponsored by Erasmus Hospital. Primary endpoint: Pharmacokinetic parameters of oseltamivir and its active metabolite. Started Nov 2009; status: completed.

02

Drugs

oseltamivir
03

Conditions

Influenza A infection

Beyond the preview

Go deeper on 2009-017350-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-017350-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call